Typicality: | 0.325 |
Saliency: | 0.176 |
on the safety benefits | 4 | other |
on pharmacokinetics | 2 | other |
about this strategy | 2 | other |
trial → provide → further data | 5 |
trial → provide → additional data | 4 |
negative | neutral | positive |
0.010 | 0.658 | 0.332 |
Raw frequency | 9 |
Normalized frequency | 0.176 |
Modifier score | 0.500 |
Perplexity | 116.535 |